EcoDrugPlus

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSMMDG00005020146
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSMMDG00005011859
Gene Symbol: INSRA
1 Cross references
213 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSMMDG00005010402
Gene Symbol: INSRB
1 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSMMDG00005013270
Gene Symbol: LOC115360133
3 Cross references
205 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSMMDG00005005409
Gene Symbol: LOC115357040
3 Cross references
203 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSMMDG00005011532
Gene Symbol: ITGB3A
1 Cross references
201 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSMMDG00005019602
Gene Symbol: ITGB3B
1 Cross references
194 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSMMDG00005019288
Gene Symbol: LOC115375120
3 Cross references
229 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSMMDG00005003271
Gene Symbol: ITGA4
1 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSMMDG00005000447
Gene Symbol: ITGA5
1 Cross references
197 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSMMDG00005024151
Gene Symbol: ITGB1
3 Cross references
213 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSMMDG00005016369
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).